Elicitation of Health State Utility Values in Retinitis Pigmentosa by Time Trade-off in the United Kingdom

Elicitation of Health State Utility Values in Retinitis Pigmentosa by Time Trade-off in the United Kingdom

Paul O’Brien,1 Ashley Enstone,2 Daisy Bridge,2 Robin Wyn,2 Judit Banhazi3 1Novartis Ireland, Dublin, Ireland; 2Adelphi Values PROVE, Bollington, UK; 3Novartis Pharma AG, Basel, SwitzerlandCorrespondence: Paul O’Brien, Email paul-2.obrien@novartis.comIntroduction: Retinitis pigmentosa (RP) is an inhe...

Full description

Bibliographic Details
Main Authors: O'Brien P, Enstone A, Bridge D, Wyn R, Banhazi J
Format: Article
Language:English
Published: Dove Medical Press 2023-01-01
Series:ClinicoEconomics and Outcomes Research
Subjects:
retinitis pigmentosa
inherited retinal disease
health state utility
health-related quality of life
time trade-off
vignette study
Online Access:https://www.dovepress.com/elicitation-of-health-state-utility-values-in-retinitis-pigmentosa-by--peer-reviewed-fulltext-article-CEOR

Internet

https://www.dovepress.com/elicitation-of-health-state-utility-values-in-retinitis-pigmentosa-by--peer-reviewed-fulltext-article-CEOR

Similar Items